Clinical Features Analysis and Survival Nomogram of Primary Small Intestinal Diffuse Large B-Cell Lymphoma

References

• Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology. 2018;50(1):74–87. doi:10.1016/j.pathol.2017.09.006
   PubMed Web of Science ®Google Scholar
• Armitage JO, Gascoyne RD, Lunning MA, et al. Non-Hodgkin lymphoma. Lancet. 2017;390(10091):298–310. doi:10.1016/S0140-6736(16)32407-2
   PubMed Web of Science ®Google Scholar
• Han Y, Yang J, Liu P, et al. Prognostic nomogram for overall survival in patients with diffuse large B-cell lymphoma. Oncologist. 2019;24(11):e1251–e1261. doi:10.1634/theoncologist.2018-0361
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the surveillance, epidemiology and end results database. Am J Hematol. 2014;89(3):310–314. doi:10.1002/ajh.23638
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen Y, Chen S, et al. Primary gastrointestinal lymphoma: a retrospective multicenter clinical study of 415 cases in Chinese Province of Guangdong and a systematic review containing 5075 Chinese patients. Medicine. 2015;94(47):e2119. doi:10.1097/MD.0000000000002119
   PubMed Web of Science ®Google Scholar
• Lin JL, Lin JX, Li P, et al. Dynamic prediction of long-term survival in patients with primary gastric diffuse large B-cell lymphoma: a SEER population-based study. BMC Cancer. 2019;19(1):873. doi:10.1186/s12885-019-5993-6
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang X, Liu Z, et al. The impact of surgery on long-term survival of patients with primary intestinal non-Hodgkin lymphomas based on SEER database. Sci Rep. 2021;11(1):23047. doi:10.1038/s41598-021-02597-1
   PubMed Web of Science ®Google Scholar
• Møller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation-a population-based study of 1575 cases. Br J Haematol. 2004;124(2):151–159. doi:10.1046/j.1365-2141.2003.04749.x
   PubMed Web of Science ®Google Scholar
• Wang C, Li W, Liu C, et al. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites[J]. Blood Cells Mol Dis. 2016;57:42–49. doi:10.1016/j.bcmd.2015.12.004
   PubMed Web of Science ®Google Scholar
• Ghimire P, Wu GY, Zhu L. Primary gastrointestinal lymphoma. World J Gastroenterol. 2011;17(6):697–707. doi:10.3748/wjg.v17.i6.697
   PubMed Web of Science ®Google Scholar
• Van Calster B, Wynants L, Verbeek JFM, et al. Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. 2018;74(6):796–804. doi:10.1016/j.eururo.2018.08.038
   PubMed Web of Science ®Google Scholar
• Hwang HS, Yoon DH, Suh C, et al. Intestinal diffuse large B-cell lymphoma: an evaluation of different staging systems. J Korean Med Sci. 2014;29(1):53–60. doi:10.3346/jkms.2014.29.1.53
   PubMed Web of Science ®Google Scholar
• Leopardo D, Di Lorenzo G, Federico P, et al. Efficacy of rituximab in gastric diffuse large B cell lymphoma patients. World J Gastroenterol. 2010;16(20):2526–2530. doi:10.3748/wjg.v16.i20.2526
   PubMed Web of Science ®Google Scholar
• Vaidya R, Habermann TM, Donohue JH, et al. Bowel perforation in intestinal lymphoma: incidence and clinical features. Ann Oncol. 2013;24(9):2439–2443. doi:10.1093/annonc/mdt188
   PubMed Web of Science ®Google Scholar
• Maeshima AM, Taniguchi H, Ito Y, et al. Clinicopathological characteristics of diffuse large B-cell lymphoma involving small and large intestines: an analysis of 126 patients. Int J Hematol. 2019;110(3):340–346. doi:10.1007/s12185-019-02687-x
   PubMed Web of Science ®Google Scholar
• Tang L, Pan Z, Zhang X. The effect of marital status on the survival of patients with multiple myeloma. Hematology. 2022;27(1):187–197. doi:10.1080/16078454.2022.2026027
   PubMed Web of Science ®Google Scholar
• Zelenetz AD, Gordon LI, Wierda WG, et al. Diffuse large B-cell lymphoma version 1.2016. J Natl Comprehensive Cancer Netw. 2016;14(2):196–231. doi:10.6004/jnccn.2016.0023
   PubMed Web of Science ®Google Scholar
• Shen Y, Ou J, Wang B, et al. Influence of severe gastrointestinal complications in primary gastrointestinal diffuse large B-cell lymphoma. Cancer Manag Res. 2021;13:1041–1052. doi:10.2147/CMAR.S295671
   PubMed Web of Science ®Google Scholar
• Schmidt W-P, Schmitz N, Sonnen R. Conservative management of gastric lymphoma: the treatment option of choice. Leuk Lymphoma. 2004;45(9):1847–1852. doi:10.1080/1042819042000219476
   PubMed Web of Science ®Google Scholar
• Mehmet K, Sener C, Uyeturk U, et al. Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology. Contemp Oncol. 2014;18(4):273–278.
   Google Scholar
• Hong YW, Kuo IM, Liu YY, et al. The role of surgical management in primary small bowel lymphoma: a single-center experience. Eur J Surg Oncol. 2017;43(10):1886–1893. doi:10.1016/j.ejso.2017.06.016
   PubMed Web of Science ®Google Scholar
• Lightner AL, Shannon E, Gibbons MM, et al. Primary gastrointestinal non-Hodgkin’s lymphoma of the small and large intestines: a systematic review. J Gastrointest Surg. 2016;20(4):827–839. doi:10.1007/s11605-015-3052-4
   PubMed Web of Science ®Google Scholar
• Lang R, Gill MJ. Diffuse Large B-Cell Lymphoma. N Engl J Med. 2021;384(23):2261–2262.
   PubMed Web of Science ®Google Scholar
• Prouet P, Giri S, Wiedower E, et al. Addition of rituximab to chemotherapy reduced the rate of surgery for gastric-DLBCL without increasing early mortality. Anticancer Res. 2017;37(2):813–817. doi:10.21873/anticanres.11382
   PubMed Web of Science ®Google Scholar
• Juárez-Salcedo LM, Sokol L, Chavez JC, et al. Primary gastric lymphoma, epidemiology, clinical diagnosis, and treatment. Cancer Control. 2018;25(1):1073274818778256. doi:10.1177/1073274818778256
   Web of Science ®Google Scholar